Global Recombinant Protein Drug Industry Market Research Report
Based on the Recombinant Protein Drug industrial chain, this report mainly elaborate the definition, types, applications and major players of Recombinant Protein Drug market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Recombinant Protein Drug market.
The Recombinant Protein Drug market can be split based on product types, major applications, and important regions.
Major Players in Recombinant Protein Drug market are:
Eli Lilly
NCPC
Changchun High & New Technology Industry
Kyowa Hakko Kirin
SL PHARM
Amgen
Shenzhen Neptunus Interlong Bio-Technique
Ortho Biotech
Livzon Pharmaceutical
Novo Nordisk
Merck Serono
GenSci
Pharmingen
Anhui Anke Biotechnology
Abcam
Roche
Sanofi
Heng Rui
Major Regions play vital role in Recombinant Protein Drug market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Recombinant Protein Drug products covered in this report are:
Recombinant Insulin
Recombinant Human Interferon (rhIFN)
Recombinant Human Erythropoietin (rhEPO)
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Recombinant Human Growth Hormone (rhGH)
Recombinant Human Follicle-stimulating Hormone (rhFSH)
Others
Most widely used downstream fields of Recombinant Protein Drug market covered in this report are:
Hospital use
Clinic use
Household
The Recombinant Protein Drug market can be split based on product types, major applications, and important regions.
Major Players in Recombinant Protein Drug market are:
Eli Lilly
NCPC
Changchun High & New Technology Industry
Kyowa Hakko Kirin
SL PHARM
Amgen
Shenzhen Neptunus Interlong Bio-Technique
Ortho Biotech
Livzon Pharmaceutical
Novo Nordisk
Merck Serono
GenSci
Pharmingen
Anhui Anke Biotechnology
Abcam
Roche
Sanofi
Heng Rui
Major Regions play vital role in Recombinant Protein Drug market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Recombinant Protein Drug products covered in this report are:
Recombinant Insulin
Recombinant Human Interferon (rhIFN)
Recombinant Human Erythropoietin (rhEPO)
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Recombinant Human Growth Hormone (rhGH)
Recombinant Human Follicle-stimulating Hormone (rhFSH)
Others
Most widely used downstream fields of Recombinant Protein Drug market covered in this report are:
Hospital use
Clinic use
Household
1 RECOMBINANT PROTEIN DRUG INTRODUCTION AND MARKET OVERVIEW
1.1 Objectives of the Study
1.2 Definition of Recombinant Protein Drug
1.3 Recombinant Protein Drug Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Recombinant Protein Drug Value ($) and Growth Rate from 2012-2022
1.4 Market Segmentation
1.4.1 Types of Recombinant Protein Drug
1.4.2 Applications of Recombinant Protein Drug
1.4.3 Research Regions
1.4.3.1 North America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.2 Europe Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.3 China Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.4 Japan Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.5 Middle East & Africa Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.6 India Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.7 South America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Recombinant Protein Drug
1.5.1.2 Growing Market of Recombinant Protein Drug
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 INDUSTRY CHAIN ANALYSIS
2.1 Upstream Raw Material Suppliers of Recombinant Protein Drug Analysis
2.2 Major Players of Recombinant Protein Drug
2.2.1 Major Players Manufacturing Base and Market Share of Recombinant Protein Drug in 2016
2.2.2 Major Players Product Types in 2016
2.3 Recombinant Protein Drug Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Recombinant Protein Drug
2.3.3 Raw Material Cost of Recombinant Protein Drug
2.3.4 Labor Cost of Recombinant Protein Drug
2.4 Market Channel Analysis of Recombinant Protein Drug
2.5 Major Downstream Buyers of Recombinant Protein Drug Analysis
3 GLOBAL RECOMBINANT PROTEIN DRUG MARKET, BY TYPE
3.1 Analysis of Market Status and Feature by Type
3.2 Global Recombinant Protein Drug Value ($) and Market Share by Type (2012-2017)
3.3 Global Recombinant Protein Drug Production and Market Share by Type (2012-2017)
3.4 Global Recombinant Protein Drug Value ($) and Growth Rate by Type (2012-2017)
3.5 Global Recombinant Protein Drug Price Analysis by Type (2012-2017)
4 RECOMBINANT PROTEIN DRUG MARKET, BY APPLICATION
4.1 Downstream Market Overview
4.2 Global Recombinant Protein Drug Consumption and Market Share by Application (2012-2017)
4.3 Downstream Buyers by Application
4.4 Global Recombinant Protein Drug Consumption and Growth Rate by Application (2012-2017)
5 GLOBAL RECOMBINANT PROTEIN DRUG PRODUCTION, VALUE ($) BY REGION (2012-2017)
5.1 Global Recombinant Protein Drug Value ($) and Market Share by Region (2012-2017)
5.2 Global Recombinant Protein Drug Production and Market Share by Region (2012-2017)
5.3 Global Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.4 North America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.5 Europe Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.6 China Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.7 Japan Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.8 Middle East & Africa Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.9 India Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.10 South America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
6 GLOBAL RECOMBINANT PROTEIN DRUG PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)
6.1 Global Recombinant Protein Drug Consumption by Regions (2012-2017)
6.2 North America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.3 Europe Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.4 China Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.5 Japan Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.6 Middle East & Africa Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.7 India Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.8 South America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
7 GLOBAL RECOMBINANT PROTEIN DRUG MARKET STATUS AND SWOT ANALYSIS BY REGIONS
7.1 North America Recombinant Protein Drug Market Status and SWOT Analysis
7.2 Europe Recombinant Protein Drug Market Status and SWOT Analysis
7.3 China Recombinant Protein Drug Market Status and SWOT Analysis
7.4 Japan Recombinant Protein Drug Market Status and SWOT Analysis
7.5 Middle East & Africa Recombinant Protein Drug Market Status and SWOT Analysis
7.6 India Recombinant Protein Drug Market Status and SWOT Analysis
7.7 South America Recombinant Protein Drug Market Status and SWOT Analysis
8 COMPETITIVE LANDSCAPE
8.1 Competitive Profile
8.2 Eli Lilly
8.2.1 Company Profiles
8.2.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.2.2.1 Product Introduction
8.2.2.2 Market Positioning and Target Customers
8.2.3 Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
8.2.4 Eli Lilly Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.3 NCPC
8.3.1 Company Profiles
8.3.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.3.2.1 Product Introduction
8.3.2.2 Market Positioning and Target Customers
8.3.3 NCPC Production, Value ($), Price, Gross Margin 2012-2017E
8.3.4 NCPC Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.4 Changchun High & New Technology Industry
8.4.1 Company Profiles
8.4.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.4.2.1 Product Introduction
8.4.2.2 Market Positioning and Target Customers
8.4.3 Changchun High & New Technology Industry Production, Value ($), Price, Gross Margin 2012-2017E
8.4.4 Changchun High & New Technology Industry Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.5 Kyowa Hakko Kirin
8.5.1 Company Profiles
8.5.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.5.2.1 Product Introduction
8.5.2.2 Market Positioning and Target Customers
8.5.3 Kyowa Hakko Kirin Production, Value ($), Price, Gross Margin 2012-2017E
8.5.4 Kyowa Hakko Kirin Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.6 SL PHARM
8.6.1 Company Profiles
8.6.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.6.2.1 Product Introduction
8.6.2.2 Market Positioning and Target Customers
8.6.3 SL PHARM Production, Value ($), Price, Gross Margin 2012-2017E
8.6.4 SL PHARM Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.7 Amgen
8.7.1 Company Profiles
8.7.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.7.2.1 Product Introduction
8.7.2.2 Market Positioning and Target Customers
8.7.3 Amgen Production, Value ($), Price, Gross Margin 2012-2017E
8.7.4 Amgen Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.8 Shenzhen Neptunus Interlong Bio-Technique
8.8.1 Company Profiles
8.8.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.8.2.1 Product Introduction
8.8.2.2 Market Positioning and Target Customers
8.8.3 Shenzhen Neptunus Interlong Bio-Technique Production, Value ($), Price, Gross Margin 2012-2017E
8.8.4 Shenzhen Neptunus Interlong Bio-Technique Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.9 Ortho Biotech
8.9.1 Company Profiles
8.9.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.9.2.1 Product Introduction
8.9.2.2 Market Positioning and Target Customers
8.9.3 Ortho Biotech Production, Value ($), Price, Gross Margin 2012-2017E
8.9.4 Ortho Biotech Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.10 Livzon Pharmaceutical
8.10.1 Company Profiles
8.10.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.10.2.1 Product Introduction
8.10.2.2 Market Positioning and Target Customers
8.10.3 Livzon Pharmaceutical Production, Value ($), Price, Gross Margin 2012-2017E
8.10.4 Livzon Pharmaceutical Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.11 Novo Nordisk
8.11.1 Company Profiles
8.11.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.11.2.1 Product Introduction
8.11.2.2 Market Positioning and Target Customers
8.11.3 Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
8.11.4 Novo Nordisk Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.12 Merck Serono
8.12.1 Company Profiles
8.12.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.12.2.1 Product Introduction
8.12.2.2 Market Positioning and Target Customers
8.12.3 Merck Serono Production, Value ($), Price, Gross Margin 2012-2017E
8.12.4 Merck Serono Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.13 GenSci
8.13.1 Company Profiles
8.13.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.13.2.1 Product Introduction
8.13.2.2 Market Positioning and Target Customers
8.13.3 GenSci Production, Value ($), Price, Gross Margin 2012-2017E
8.13.4 GenSci Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.14 Pharmingen
8.14.1 Company Profiles
8.14.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.14.2.1 Product Introduction
8.14.2.2 Market Positioning and Target Customers
8.14.3 Pharmingen Production, Value ($), Price, Gross Margin 2012-2017E
8.14.4 Pharmingen Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.15 Anhui Anke Biotechnology
8.15.1 Company Profiles
8.15.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.15.2.1 Product Introduction
8.15.2.2 Market Positioning and Target Customers
8.15.3 Anhui Anke Biotechnology Production, Value ($), Price, Gross Margin 2012-2017E
8.15.4 Anhui Anke Biotechnology Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.16 Abcam
8.16.1 Company Profiles
8.16.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.16.2.1 Product Introduction
8.16.2.2 Market Positioning and Target Customers
8.16.3 Abcam Production, Value ($), Price, Gross Margin 2012-2017E
8.16.4 Abcam Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.17 Roche
8.18 Sanofi
8.19 Heng Rui
9 GLOBAL RECOMBINANT PROTEIN DRUG MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION
9.1 Global Recombinant Protein Drug Market Value ($) & Volume Forecast, by Type (2017-2022)
9.1.1 Recombinant Insulin Market Value ($) and Volume Forecast (2017-2022)
9.1.2 Recombinant Human Interferon (rhIFN) Market Value ($) and Volume Forecast (2017-2022)
9.1.3 Recombinant Human Erythropoietin (rhEPO) Market Value ($) and Volume Forecast (2017-2022)
9.1.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Market Value ($) and Volume Forecast (2017-2022)
9.1.5 Recombinant Human Growth Hormone (rhGH) Market Value ($) and Volume Forecast (2017-2022)
9.1.6 Recombinant Human Follicle-stimulating Hormone (rhFSH) Market Value ($) and Volume Forecast (2017-2022)
9.1.7 Others Market Value ($) and Volume Forecast (2017-2022)
9.2 Global Recombinant Protein Drug Market Value ($) & Volume Forecast, by Application (2017-2022)
9.2.1 Hospital use Market Value ($) and Volume Forecast (2017-2022)
9.2.2 Clinic use Market Value ($) and Volume Forecast (2017-2022)
9.2.3 Household Market Value ($) and Volume Forecast (2017-2022)
10 RECOMBINANT PROTEIN DRUG MARKET ANALYSIS AND FORECAST BY REGION
10.1 North America Market Value ($) and Consumption Forecast (2017-2022)
10.2 Europe Market Value ($) and Consumption Forecast (2017-2022)
10.3 China Market Value ($) and Consumption Forecast (2017-2022)
10.4 Japan Market Value ($) and Consumption Forecast (2017-2022)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2017-2022)
10.6 India Market Value ($) and Consumption Forecast (2017-2022)
10.7 South America Market Value ($) and Consumption Forecast (2017-2022)
11 NEW PROJECT FEASIBILITY ANALYSIS
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 RESEARCH FINDING AND CONCLUSION
13 APPENDIX
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
1.1 Objectives of the Study
1.2 Definition of Recombinant Protein Drug
1.3 Recombinant Protein Drug Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Recombinant Protein Drug Value ($) and Growth Rate from 2012-2022
1.4 Market Segmentation
1.4.1 Types of Recombinant Protein Drug
1.4.2 Applications of Recombinant Protein Drug
1.4.3 Research Regions
1.4.3.1 North America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.2 Europe Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.3 China Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.4 Japan Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.5 Middle East & Africa Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.6 India Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.4.3.7 South America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Recombinant Protein Drug
1.5.1.2 Growing Market of Recombinant Protein Drug
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 INDUSTRY CHAIN ANALYSIS
2.1 Upstream Raw Material Suppliers of Recombinant Protein Drug Analysis
2.2 Major Players of Recombinant Protein Drug
2.2.1 Major Players Manufacturing Base and Market Share of Recombinant Protein Drug in 2016
2.2.2 Major Players Product Types in 2016
2.3 Recombinant Protein Drug Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Recombinant Protein Drug
2.3.3 Raw Material Cost of Recombinant Protein Drug
2.3.4 Labor Cost of Recombinant Protein Drug
2.4 Market Channel Analysis of Recombinant Protein Drug
2.5 Major Downstream Buyers of Recombinant Protein Drug Analysis
3 GLOBAL RECOMBINANT PROTEIN DRUG MARKET, BY TYPE
3.1 Analysis of Market Status and Feature by Type
3.2 Global Recombinant Protein Drug Value ($) and Market Share by Type (2012-2017)
3.3 Global Recombinant Protein Drug Production and Market Share by Type (2012-2017)
3.4 Global Recombinant Protein Drug Value ($) and Growth Rate by Type (2012-2017)
3.5 Global Recombinant Protein Drug Price Analysis by Type (2012-2017)
4 RECOMBINANT PROTEIN DRUG MARKET, BY APPLICATION
4.1 Downstream Market Overview
4.2 Global Recombinant Protein Drug Consumption and Market Share by Application (2012-2017)
4.3 Downstream Buyers by Application
4.4 Global Recombinant Protein Drug Consumption and Growth Rate by Application (2012-2017)
5 GLOBAL RECOMBINANT PROTEIN DRUG PRODUCTION, VALUE ($) BY REGION (2012-2017)
5.1 Global Recombinant Protein Drug Value ($) and Market Share by Region (2012-2017)
5.2 Global Recombinant Protein Drug Production and Market Share by Region (2012-2017)
5.3 Global Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.4 North America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.5 Europe Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.6 China Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.7 Japan Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.8 Middle East & Africa Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.9 India Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
5.10 South America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
6 GLOBAL RECOMBINANT PROTEIN DRUG PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)
6.1 Global Recombinant Protein Drug Consumption by Regions (2012-2017)
6.2 North America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.3 Europe Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.4 China Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.5 Japan Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.6 Middle East & Africa Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.7 India Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
6.8 South America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
7 GLOBAL RECOMBINANT PROTEIN DRUG MARKET STATUS AND SWOT ANALYSIS BY REGIONS
7.1 North America Recombinant Protein Drug Market Status and SWOT Analysis
7.2 Europe Recombinant Protein Drug Market Status and SWOT Analysis
7.3 China Recombinant Protein Drug Market Status and SWOT Analysis
7.4 Japan Recombinant Protein Drug Market Status and SWOT Analysis
7.5 Middle East & Africa Recombinant Protein Drug Market Status and SWOT Analysis
7.6 India Recombinant Protein Drug Market Status and SWOT Analysis
7.7 South America Recombinant Protein Drug Market Status and SWOT Analysis
8 COMPETITIVE LANDSCAPE
8.1 Competitive Profile
8.2 Eli Lilly
8.2.1 Company Profiles
8.2.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.2.2.1 Product Introduction
8.2.2.2 Market Positioning and Target Customers
8.2.3 Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
8.2.4 Eli Lilly Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.3 NCPC
8.3.1 Company Profiles
8.3.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.3.2.1 Product Introduction
8.3.2.2 Market Positioning and Target Customers
8.3.3 NCPC Production, Value ($), Price, Gross Margin 2012-2017E
8.3.4 NCPC Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.4 Changchun High & New Technology Industry
8.4.1 Company Profiles
8.4.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.4.2.1 Product Introduction
8.4.2.2 Market Positioning and Target Customers
8.4.3 Changchun High & New Technology Industry Production, Value ($), Price, Gross Margin 2012-2017E
8.4.4 Changchun High & New Technology Industry Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.5 Kyowa Hakko Kirin
8.5.1 Company Profiles
8.5.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.5.2.1 Product Introduction
8.5.2.2 Market Positioning and Target Customers
8.5.3 Kyowa Hakko Kirin Production, Value ($), Price, Gross Margin 2012-2017E
8.5.4 Kyowa Hakko Kirin Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.6 SL PHARM
8.6.1 Company Profiles
8.6.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.6.2.1 Product Introduction
8.6.2.2 Market Positioning and Target Customers
8.6.3 SL PHARM Production, Value ($), Price, Gross Margin 2012-2017E
8.6.4 SL PHARM Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.7 Amgen
8.7.1 Company Profiles
8.7.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.7.2.1 Product Introduction
8.7.2.2 Market Positioning and Target Customers
8.7.3 Amgen Production, Value ($), Price, Gross Margin 2012-2017E
8.7.4 Amgen Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.8 Shenzhen Neptunus Interlong Bio-Technique
8.8.1 Company Profiles
8.8.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.8.2.1 Product Introduction
8.8.2.2 Market Positioning and Target Customers
8.8.3 Shenzhen Neptunus Interlong Bio-Technique Production, Value ($), Price, Gross Margin 2012-2017E
8.8.4 Shenzhen Neptunus Interlong Bio-Technique Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.9 Ortho Biotech
8.9.1 Company Profiles
8.9.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.9.2.1 Product Introduction
8.9.2.2 Market Positioning and Target Customers
8.9.3 Ortho Biotech Production, Value ($), Price, Gross Margin 2012-2017E
8.9.4 Ortho Biotech Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.10 Livzon Pharmaceutical
8.10.1 Company Profiles
8.10.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.10.2.1 Product Introduction
8.10.2.2 Market Positioning and Target Customers
8.10.3 Livzon Pharmaceutical Production, Value ($), Price, Gross Margin 2012-2017E
8.10.4 Livzon Pharmaceutical Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.11 Novo Nordisk
8.11.1 Company Profiles
8.11.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.11.2.1 Product Introduction
8.11.2.2 Market Positioning and Target Customers
8.11.3 Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
8.11.4 Novo Nordisk Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.12 Merck Serono
8.12.1 Company Profiles
8.12.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.12.2.1 Product Introduction
8.12.2.2 Market Positioning and Target Customers
8.12.3 Merck Serono Production, Value ($), Price, Gross Margin 2012-2017E
8.12.4 Merck Serono Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.13 GenSci
8.13.1 Company Profiles
8.13.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.13.2.1 Product Introduction
8.13.2.2 Market Positioning and Target Customers
8.13.3 GenSci Production, Value ($), Price, Gross Margin 2012-2017E
8.13.4 GenSci Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.14 Pharmingen
8.14.1 Company Profiles
8.14.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.14.2.1 Product Introduction
8.14.2.2 Market Positioning and Target Customers
8.14.3 Pharmingen Production, Value ($), Price, Gross Margin 2012-2017E
8.14.4 Pharmingen Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.15 Anhui Anke Biotechnology
8.15.1 Company Profiles
8.15.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.15.2.1 Product Introduction
8.15.2.2 Market Positioning and Target Customers
8.15.3 Anhui Anke Biotechnology Production, Value ($), Price, Gross Margin 2012-2017E
8.15.4 Anhui Anke Biotechnology Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.16 Abcam
8.16.1 Company Profiles
8.16.2 Recombinant Protein Drug Product Introduction and Market Positioning
8.16.2.1 Product Introduction
8.16.2.2 Market Positioning and Target Customers
8.16.3 Abcam Production, Value ($), Price, Gross Margin 2012-2017E
8.16.4 Abcam Market Share of Recombinant Protein Drug Segmented by Region in 2016
8.17 Roche
8.18 Sanofi
8.19 Heng Rui
9 GLOBAL RECOMBINANT PROTEIN DRUG MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION
9.1 Global Recombinant Protein Drug Market Value ($) & Volume Forecast, by Type (2017-2022)
9.1.1 Recombinant Insulin Market Value ($) and Volume Forecast (2017-2022)
9.1.2 Recombinant Human Interferon (rhIFN) Market Value ($) and Volume Forecast (2017-2022)
9.1.3 Recombinant Human Erythropoietin (rhEPO) Market Value ($) and Volume Forecast (2017-2022)
9.1.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Market Value ($) and Volume Forecast (2017-2022)
9.1.5 Recombinant Human Growth Hormone (rhGH) Market Value ($) and Volume Forecast (2017-2022)
9.1.6 Recombinant Human Follicle-stimulating Hormone (rhFSH) Market Value ($) and Volume Forecast (2017-2022)
9.1.7 Others Market Value ($) and Volume Forecast (2017-2022)
9.2 Global Recombinant Protein Drug Market Value ($) & Volume Forecast, by Application (2017-2022)
9.2.1 Hospital use Market Value ($) and Volume Forecast (2017-2022)
9.2.2 Clinic use Market Value ($) and Volume Forecast (2017-2022)
9.2.3 Household Market Value ($) and Volume Forecast (2017-2022)
10 RECOMBINANT PROTEIN DRUG MARKET ANALYSIS AND FORECAST BY REGION
10.1 North America Market Value ($) and Consumption Forecast (2017-2022)
10.2 Europe Market Value ($) and Consumption Forecast (2017-2022)
10.3 China Market Value ($) and Consumption Forecast (2017-2022)
10.4 Japan Market Value ($) and Consumption Forecast (2017-2022)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2017-2022)
10.6 India Market Value ($) and Consumption Forecast (2017-2022)
10.7 South America Market Value ($) and Consumption Forecast (2017-2022)
11 NEW PROJECT FEASIBILITY ANALYSIS
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 RESEARCH FINDING AND CONCLUSION
13 APPENDIX
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
LIST OF TABLES AND FIGURES
Figure Product Picture of Recombinant Protein Drug
Table Product Specification of Recombinant Protein Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Recombinant Protein Drug
Figure Global Recombinant Protein Drug Value ($) and Growth Rate from 2012-2022
Table Different Types of Recombinant Protein Drug
Figure Global Recombinant Protein Drug Value ($) Segment by Type from 2012-2017
Figure Recombinant Insulin Picture
Figure Recombinant Human Interferon (rhIFN) Picture
Figure Recombinant Human Erythropoietin (rhEPO) Picture
Figure Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Picture
Figure Recombinant Human Growth Hormone (rhGH) Picture
Figure Recombinant Human Follicle-stimulating Hormone (rhFSH) Picture
Figure Others Picture
Table Different Applications of Recombinant Protein Drug
Figure Global Recombinant Protein Drug Value ($) Segment by Applications from 2012-2017
Figure Hospital use Picture
Figure Clinic use Picture
Figure Household Picture
Table Research Regions of Recombinant Protein Drug
Figure North America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Figure Europe Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table China Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table Japan Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table Middle East & Africa Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table India Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table South America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table Emerging Countries of Recombinant Protein Drug
Table Growing Market of Recombinant Protein Drug
Figure Industry Chain Analysis of Recombinant Protein Drug
Table Upstream Raw Material Suppliers of Recombinant Protein Drug with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Recombinant Protein Drug in 2016
Table Major Players Recombinant Protein Drug Product Types in 2016
Figure Production Process of Recombinant Protein Drug
Figure Manufacturing Cost Structure of Recombinant Protein Drug
Figure Channel Status of Recombinant Protein Drug
Table Major Distributors of Recombinant Protein Drug with Contact Information
Table Major Downstream Buyers of Recombinant Protein Drug with Contact Information
Table Analysis of Market Status and Feature by Type
Table Global Recombinant Protein Drug Value ($) by Type (2012-2017)
Table Global Recombinant Protein Drug Value ($) Share by Type (2012-2017)
Figure Global Recombinant Protein Drug Value ($) Share by Type (2012-2017)
Table Global Recombinant Protein Drug Production by Type (2012-2017)
Table Global Recombinant Protein Drug Production Share by Type (2012-2017)
Figure Global Recombinant Protein Drug Production Share by Type (2012-2017)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Insulin
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Interferon (rhIFN)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Erythropoietin (rhEPO)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Growth Hormone (rhGH)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Others
Table Global Recombinant Protein Drug Price by Type (2012-2017)
Figure Downstream Market Overview
Table Global Recombinant Protein Drug Consumption by Application (2012-2017)
Table Global Recombinant Protein Drug Consumption Market Share by Application (2012-2017)
Figure Global Recombinant Protein Drug Consumption Market Share by Application (2012-2017)
Table Downstream Buyers Introduction by Application
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Household (2012-2017)
Table Global Recombinant Protein Drug Value ($) by Region (2012-2017)
Table Global Recombinant Protein Drug Value ($) Market Share by Region (2012-2017)
Figure Global Recombinant Protein Drug Value ($) Market Share by Region (2012-2017)
Table Global Recombinant Protein Drug Production by Region (2012-2017)
Table Global Recombinant Protein Drug Production Market Share by Region (2012-2017)
Figure Global Recombinant Protein Drug Production Market Share by Region (2012-2017)
Table Global Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table North America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Europe Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table China Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Japan Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Middle East & Africa Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table India Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table South America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Global Recombinant Protein Drug Consumption by Regions (2012-2017)
Figure Global Recombinant Protein Drug Consumption Share by Regions (2012-2017)
Table North America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table Europe Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table China Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table Japan Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table Middle East & Africa Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table India Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table South America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Figure North America Recombinant Protein Drug Production and Growth Rate Analysis
Figure North America Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure North America Recombinant Protein Drug SWOT Analysis
Figure Europe Recombinant Protein Drug Production and Growth Rate Analysis
Figure Europe Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure Europe Recombinant Protein Drug SWOT Analysis
Figure China Recombinant Protein Drug Production and Growth Rate Analysis
Figure China Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure China Recombinant Protein Drug SWOT Analysis
Figure Japan Recombinant Protein Drug Production and Growth Rate Analysis
Figure Japan Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure Japan Recombinant Protein Drug SWOT Analysis
Figure Middle East & Africa Recombinant Protein Drug Production and Growth Rate Analysis
Figure Middle East & Africa Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure Middle East & Africa Recombinant Protein Drug SWOT Analysis
Figure India Recombinant Protein Drug Production and Growth Rate Analysis
Figure India Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure India Recombinant Protein Drug SWOT Analysis
Figure South America Recombinant Protein Drug Production and Growth Rate Analysis
Figure South America Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure South America Recombinant Protein Drug SWOT Analysis
Figure Competitive Matrix and Pattern Characteristics of Recombinant Protein Drug Market
Figure Top 3 Market Share of Recombinant Protein Drug Companies
Figure Top 6 Market Share of Recombinant Protein Drug Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2012-2017E
Figure Eli Lilly Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table NCPC Production, Value ($), Price, Gross Margin 2012-2017E
Figure NCPC Production and Growth Rate
Figure NCPC Value ($) Market Share 2012-2017E
Figure NCPC Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Changchun High & New Technology Industry Production, Value ($), Price, Gross Margin 2012-2017E
Figure Changchun High & New Technology Industry Production and Growth Rate
Figure Changchun High & New Technology Industry Value ($) Market Share 2012-2017E
Figure Changchun High & New Technology Industry Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Kyowa Hakko Kirin Production, Value ($), Price, Gross Margin 2012-2017E
Figure Kyowa Hakko Kirin Production and Growth Rate
Figure Kyowa Hakko Kirin Value ($) Market Share 2012-2017E
Figure Kyowa Hakko Kirin Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table SL PHARM Production, Value ($), Price, Gross Margin 2012-2017E
Figure SL PHARM Production and Growth Rate
Figure SL PHARM Value ($) Market Share 2012-2017E
Figure SL PHARM Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Amgen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2012-2017E
Figure Amgen Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Shenzhen Neptunus Interlong Bio-Technique Production, Value ($), Price, Gross Margin 2012-2017E
Figure Shenzhen Neptunus Interlong Bio-Technique Production and Growth Rate
Figure Shenzhen Neptunus Interlong Bio-Technique Value ($) Market Share 2012-2017E
Figure Shenzhen Neptunus Interlong Bio-Technique Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Ortho Biotech Production, Value ($), Price, Gross Margin 2012-2017E
Figure Ortho Biotech Production and Growth Rate
Figure Ortho Biotech Value ($) Market Share 2012-2017E
Figure Ortho Biotech Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Livzon Pharmaceutical Production, Value ($), Price, Gross Margin 2012-2017E
Figure Livzon Pharmaceutical Production and Growth Rate
Figure Livzon Pharmaceutical Value ($) Market Share 2012-2017E
Figure Livzon Pharmaceutical Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2012-2017E
Figure Novo Nordisk Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Merck Serono Production, Value ($), Price, Gross Margin 2012-2017E
Figure Merck Serono Production and Growth Rate
Figure Merck Serono Value ($) Market Share 2012-2017E
Figure Merck Serono Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table GenSci Production, Value ($), Price, Gross Margin 2012-2017E
Figure GenSci Production and Growth Rate
Figure GenSci Value ($) Market Share 2012-2017E
Figure GenSci Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Pharmingen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Pharmingen Production and Growth Rate
Figure Pharmingen Value ($) Market Share 2012-2017E
Figure Pharmingen Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Anhui Anke Biotechnology Production, Value ($), Price, Gross Margin 2012-2017E
Figure Anhui Anke Biotechnology Production and Growth Rate
Figure Anhui Anke Biotechnology Value ($) Market Share 2012-2017E
Figure Anhui Anke Biotechnology Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Abcam Production, Value ($), Price, Gross Margin 2012-2017E
Figure Abcam Production and Growth Rate
Figure Abcam Value ($) Market Share 2012-2017E
Figure Abcam Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Roche Production, Value ($), Price, Gross Margin 2012-2017E
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2012-2017E
Figure Roche Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Sanofi Production, Value ($), Price, Gross Margin 2012-2017E
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2012-2017E
Figure Sanofi Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Heng Rui Production, Value ($), Price, Gross Margin 2012-2017E
Figure Heng Rui Production and Growth Rate
Figure Heng Rui Value ($) Market Share 2012-2017E
Figure Heng Rui Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Global Recombinant Protein Drug Market Value ($) Forecast, by Type
Table Global Recombinant Protein Drug Market Volume Forecast, by Type
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Others (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Others (2017-2022)
Table Global Market Value ($) Forecast by Application (2017-2022)
Table Global Market Volume Forecast by Application (2017-2022)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Household (2012-2017)
Figure Market Value ($) and Growth Rate Forecast of Household (2017-2022)
Figure Market Volume and Growth Rate Forecast of Household (2017-2022)
Figure North America Market Value ($) and Growth Rate Forecast (2017-2022)
Table North America Consumption and Growth Rate Forecast (2017-2022)
Figure Europe Market Value ($) and Growth Rate Forecast (2017-2022)
Table Europe Consumption and Growth Rate Forecast (2017-2022)
Figure China Market Value ($) and Growth Rate Forecast (2017-2022)
Table China Consumption and Growth Rate Forecast (2017-2022)
Figure Japan Market Value ($) and Growth Rate Forecast (2017-2022)
Table Japan Consumption and Growth Rate Forecast (2017-2022)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2017-2022)
Table Middle East & Africa Consumption and Growth Rate Forecast (2017-2022)
Figure India Market Value ($) and Growth Rate Forecast (2017-2022)
Table India Consumption and Growth Rate Forecast (2017-2022)
Figure South America Market Value ($) and Growth Rate Forecast (2017-2022)
Table South America Consumption and Growth Rate Forecast (2017-2022)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Figure Product Picture of Recombinant Protein Drug
Table Product Specification of Recombinant Protein Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Recombinant Protein Drug
Figure Global Recombinant Protein Drug Value ($) and Growth Rate from 2012-2022
Table Different Types of Recombinant Protein Drug
Figure Global Recombinant Protein Drug Value ($) Segment by Type from 2012-2017
Figure Recombinant Insulin Picture
Figure Recombinant Human Interferon (rhIFN) Picture
Figure Recombinant Human Erythropoietin (rhEPO) Picture
Figure Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Picture
Figure Recombinant Human Growth Hormone (rhGH) Picture
Figure Recombinant Human Follicle-stimulating Hormone (rhFSH) Picture
Figure Others Picture
Table Different Applications of Recombinant Protein Drug
Figure Global Recombinant Protein Drug Value ($) Segment by Applications from 2012-2017
Figure Hospital use Picture
Figure Clinic use Picture
Figure Household Picture
Table Research Regions of Recombinant Protein Drug
Figure North America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Figure Europe Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table China Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table Japan Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table Middle East & Africa Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table India Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table South America Recombinant Protein Drug Production Value ($) and Growth Rate (2012-2017)
Table Emerging Countries of Recombinant Protein Drug
Table Growing Market of Recombinant Protein Drug
Figure Industry Chain Analysis of Recombinant Protein Drug
Table Upstream Raw Material Suppliers of Recombinant Protein Drug with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Recombinant Protein Drug in 2016
Table Major Players Recombinant Protein Drug Product Types in 2016
Figure Production Process of Recombinant Protein Drug
Figure Manufacturing Cost Structure of Recombinant Protein Drug
Figure Channel Status of Recombinant Protein Drug
Table Major Distributors of Recombinant Protein Drug with Contact Information
Table Major Downstream Buyers of Recombinant Protein Drug with Contact Information
Table Analysis of Market Status and Feature by Type
Table Global Recombinant Protein Drug Value ($) by Type (2012-2017)
Table Global Recombinant Protein Drug Value ($) Share by Type (2012-2017)
Figure Global Recombinant Protein Drug Value ($) Share by Type (2012-2017)
Table Global Recombinant Protein Drug Production by Type (2012-2017)
Table Global Recombinant Protein Drug Production Share by Type (2012-2017)
Figure Global Recombinant Protein Drug Production Share by Type (2012-2017)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Insulin
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Interferon (rhIFN)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Erythropoietin (rhEPO)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Growth Hormone (rhGH)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH)
Figure Global Recombinant Protein Drug Value ($) and Growth Rate of Others
Table Global Recombinant Protein Drug Price by Type (2012-2017)
Figure Downstream Market Overview
Table Global Recombinant Protein Drug Consumption by Application (2012-2017)
Table Global Recombinant Protein Drug Consumption Market Share by Application (2012-2017)
Figure Global Recombinant Protein Drug Consumption Market Share by Application (2012-2017)
Table Downstream Buyers Introduction by Application
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Household (2012-2017)
Table Global Recombinant Protein Drug Value ($) by Region (2012-2017)
Table Global Recombinant Protein Drug Value ($) Market Share by Region (2012-2017)
Figure Global Recombinant Protein Drug Value ($) Market Share by Region (2012-2017)
Table Global Recombinant Protein Drug Production by Region (2012-2017)
Table Global Recombinant Protein Drug Production Market Share by Region (2012-2017)
Figure Global Recombinant Protein Drug Production Market Share by Region (2012-2017)
Table Global Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table North America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Europe Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table China Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Japan Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Middle East & Africa Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table India Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table South America Recombinant Protein Drug Production, Value ($), Price and Gross Margin (2012-2017)
Table Global Recombinant Protein Drug Consumption by Regions (2012-2017)
Figure Global Recombinant Protein Drug Consumption Share by Regions (2012-2017)
Table North America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table Europe Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table China Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table Japan Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table Middle East & Africa Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table India Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Table South America Recombinant Protein Drug Production, Consumption, Export, Import (2012-2017)
Figure North America Recombinant Protein Drug Production and Growth Rate Analysis
Figure North America Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure North America Recombinant Protein Drug SWOT Analysis
Figure Europe Recombinant Protein Drug Production and Growth Rate Analysis
Figure Europe Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure Europe Recombinant Protein Drug SWOT Analysis
Figure China Recombinant Protein Drug Production and Growth Rate Analysis
Figure China Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure China Recombinant Protein Drug SWOT Analysis
Figure Japan Recombinant Protein Drug Production and Growth Rate Analysis
Figure Japan Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure Japan Recombinant Protein Drug SWOT Analysis
Figure Middle East & Africa Recombinant Protein Drug Production and Growth Rate Analysis
Figure Middle East & Africa Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure Middle East & Africa Recombinant Protein Drug SWOT Analysis
Figure India Recombinant Protein Drug Production and Growth Rate Analysis
Figure India Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure India Recombinant Protein Drug SWOT Analysis
Figure South America Recombinant Protein Drug Production and Growth Rate Analysis
Figure South America Recombinant Protein Drug Consumption and Growth Rate Analysis
Figure South America Recombinant Protein Drug SWOT Analysis
Figure Competitive Matrix and Pattern Characteristics of Recombinant Protein Drug Market
Figure Top 3 Market Share of Recombinant Protein Drug Companies
Figure Top 6 Market Share of Recombinant Protein Drug Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2012-2017E
Figure Eli Lilly Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table NCPC Production, Value ($), Price, Gross Margin 2012-2017E
Figure NCPC Production and Growth Rate
Figure NCPC Value ($) Market Share 2012-2017E
Figure NCPC Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Changchun High & New Technology Industry Production, Value ($), Price, Gross Margin 2012-2017E
Figure Changchun High & New Technology Industry Production and Growth Rate
Figure Changchun High & New Technology Industry Value ($) Market Share 2012-2017E
Figure Changchun High & New Technology Industry Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Kyowa Hakko Kirin Production, Value ($), Price, Gross Margin 2012-2017E
Figure Kyowa Hakko Kirin Production and Growth Rate
Figure Kyowa Hakko Kirin Value ($) Market Share 2012-2017E
Figure Kyowa Hakko Kirin Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table SL PHARM Production, Value ($), Price, Gross Margin 2012-2017E
Figure SL PHARM Production and Growth Rate
Figure SL PHARM Value ($) Market Share 2012-2017E
Figure SL PHARM Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Amgen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2012-2017E
Figure Amgen Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Shenzhen Neptunus Interlong Bio-Technique Production, Value ($), Price, Gross Margin 2012-2017E
Figure Shenzhen Neptunus Interlong Bio-Technique Production and Growth Rate
Figure Shenzhen Neptunus Interlong Bio-Technique Value ($) Market Share 2012-2017E
Figure Shenzhen Neptunus Interlong Bio-Technique Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Ortho Biotech Production, Value ($), Price, Gross Margin 2012-2017E
Figure Ortho Biotech Production and Growth Rate
Figure Ortho Biotech Value ($) Market Share 2012-2017E
Figure Ortho Biotech Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Livzon Pharmaceutical Production, Value ($), Price, Gross Margin 2012-2017E
Figure Livzon Pharmaceutical Production and Growth Rate
Figure Livzon Pharmaceutical Value ($) Market Share 2012-2017E
Figure Livzon Pharmaceutical Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2012-2017E
Figure Novo Nordisk Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Merck Serono Production, Value ($), Price, Gross Margin 2012-2017E
Figure Merck Serono Production and Growth Rate
Figure Merck Serono Value ($) Market Share 2012-2017E
Figure Merck Serono Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table GenSci Production, Value ($), Price, Gross Margin 2012-2017E
Figure GenSci Production and Growth Rate
Figure GenSci Value ($) Market Share 2012-2017E
Figure GenSci Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Pharmingen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Pharmingen Production and Growth Rate
Figure Pharmingen Value ($) Market Share 2012-2017E
Figure Pharmingen Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Anhui Anke Biotechnology Production, Value ($), Price, Gross Margin 2012-2017E
Figure Anhui Anke Biotechnology Production and Growth Rate
Figure Anhui Anke Biotechnology Value ($) Market Share 2012-2017E
Figure Anhui Anke Biotechnology Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Abcam Production, Value ($), Price, Gross Margin 2012-2017E
Figure Abcam Production and Growth Rate
Figure Abcam Value ($) Market Share 2012-2017E
Figure Abcam Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Roche Production, Value ($), Price, Gross Margin 2012-2017E
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2012-2017E
Figure Roche Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Sanofi Production, Value ($), Price, Gross Margin 2012-2017E
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2012-2017E
Figure Sanofi Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Heng Rui Production, Value ($), Price, Gross Margin 2012-2017E
Figure Heng Rui Production and Growth Rate
Figure Heng Rui Value ($) Market Share 2012-2017E
Figure Heng Rui Market Share of Recombinant Protein Drug Segmented by Region in 2016
Table Global Recombinant Protein Drug Market Value ($) Forecast, by Type
Table Global Recombinant Protein Drug Market Volume Forecast, by Type
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Market Value ($) and Growth Rate Forecast of Others (2017-2022)
Figure Global Recombinant Protein Drug Market Volume and Growth Rate Forecast of Others (2017-2022)
Table Global Market Value ($) Forecast by Application (2017-2022)
Table Global Market Volume Forecast by Application (2017-2022)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2012-2017)
Figure Global Recombinant Protein Drug Consumption and Growth Rate of Household (2012-2017)
Figure Market Value ($) and Growth Rate Forecast of Household (2017-2022)
Figure Market Volume and Growth Rate Forecast of Household (2017-2022)
Figure North America Market Value ($) and Growth Rate Forecast (2017-2022)
Table North America Consumption and Growth Rate Forecast (2017-2022)
Figure Europe Market Value ($) and Growth Rate Forecast (2017-2022)
Table Europe Consumption and Growth Rate Forecast (2017-2022)
Figure China Market Value ($) and Growth Rate Forecast (2017-2022)
Table China Consumption and Growth Rate Forecast (2017-2022)
Figure Japan Market Value ($) and Growth Rate Forecast (2017-2022)
Table Japan Consumption and Growth Rate Forecast (2017-2022)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2017-2022)
Table Middle East & Africa Consumption and Growth Rate Forecast (2017-2022)
Figure India Market Value ($) and Growth Rate Forecast (2017-2022)
Table India Consumption and Growth Rate Forecast (2017-2022)
Figure South America Market Value ($) and Growth Rate Forecast (2017-2022)
Table South America Consumption and Growth Rate Forecast (2017-2022)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
